Clinical Trials Browser

Terminated × Hepatitis C × Clear all

Fibrosis, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Hypothermia, Liver Cirrhosis, Alcoholic, Renal Insufficiency, Chronic, Acute Kidney Injury, End Stage Liver Disease, Non-alcoholic Fatty Liver Disease

NCT05184283 2023-12-07

Utilization of MAsS in Patients Undergoing LT for HCC

Terminated

11 enrolled

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Diseases, Liver Neoplasms, Non-alcoholic Fatty Liver Disease

NCT00375011 2022-12-20

Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics

Terminated

200 enrolled

Gastrointestinal

Fibrosis, Hepatitis C, Carcinoma, Hepatocellular

NCT01821963 2020-09-24

Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)

Phase 3 Terminated

1 enrolled 3 charts

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular, Infections

NCT02717949 2019-01-08

Optimal

Phase 4 Terminated

1 enrolled

Lymphoid

Hepatitis C, Liver Diseases, Lymphoma, Non-Hodgkin

NCT00767936 2016-06-29

Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma

Terminated

135 enrolled

Gastrointestinal

Hepatitis B, Hepatitis C, Liver Neoplasms

NCT00897312 2016-04-25

Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease

Terminated

7 enrolled

DermatologicOther neoplasm

Hepatitis C, Melanoma, Precancerous Conditions

Clinical Trials

MHALT

Utilization of MAsS in Patients Undergoing LT for HCC

Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics

Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)

Optimal

Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma

Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease